慢性肾脏病4~5期合并妊娠的临床特点与母儿结局
回顾性分析重庆医科大学附属第三医院CKD妊娠MDT门诊2019年9月至2024年7月收治的10例CKD 4~5期孕妇,其中6例成功分娩,均为早产儿,无胎死宫内及新生儿死亡,无产后出血,随访新生儿生长发育良好。结论认为CKD 4~5期非妊娠绝对禁忌,MDT精准管理、密切母胎监测、生活方式干预和适时透析有助于获得良好母儿结局。
要点
- CKD 4~5期非妊娠绝对禁忌,需充分医患沟通与共同决策。
- MDT精准管理、密切母胎监测和生活方式医学干预是关键。
- 适时启动透析有助于CKD 4~5期孕妇安全妊娠。
核心结论
- CKD 4~5期非妊娠绝对禁忌,全面评估、医患共同决策、MDT精准管理、密切母胎监测、生活方式医学干预和适时启动透析可助力安全妊娠并获得良好母儿结局。
研究设计与样本
- 回顾性分析2019年9月至2024年7月重庆医科大学附属第三医院CKD妊娠MDT门诊收治的CKD 4~5期孕妇10例,重点分析成功分娩孕妇的病史、实验室检查、妊娠结局、治疗方案和肾功能转归。
主要发现
- 10例孕妇年龄(29.0±4.2)岁(范围23~36岁),3例妊娠中期引产,1例妊娠早期稽留流产,6例成功分娩。
- 4例行肾穿刺活检明确原发性肾病类型,4例完善基因检测确诊遗传性肾病。
- 成功分娩的6例中,3例妊娠中晚期启动透析,另3例分别于产后即刻、产后5.5月、产后18.3月启动透析。
- 所有孕妇均行剖宫产终止妊娠,分娩孕周(33.8±1.1)周(范围32+1~35+1周),均为早产儿,无胎死宫内及新生儿死亡,无产后出血。
- 2例小于胎龄儿,4例适于胎龄儿;NICU入住时间(23.0±11.0)d(范围10~38 d),无严重并发症,随访10~60个月生长发育良好。
关键数值与推荐
- CKD 4~5期孕妇分娩孕周(33.8±1.1)周(范围32+1~35+1周),均为早产儿。
- NICU入住时间(23.0±11.0)d(范围10~38 d),入住期间无严重并发症。
- 随访新生儿10~60个月,均生长发育良好。
临床怎么用
- 对CKD 4~5期孕妇应进行全面评估和充分医患沟通,实施医患共同决策。
- 推荐MDT精准管理、密切母胎监测、生活方式医学干预,并适时启动透析。
局限性
- 本研究为单中心回顾性分析,样本量仅10例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To summarize the clinical characteristics, management and short-term and long-term outcomes of pregnant women with chronic kidney disease (CKD) stage 4-5. Methods: The clinical data of pregnant women with CKD stage 4-5 admitted by the multidisciplinary team (MDT) of CKD pregnancy management in the Third Affiliated Hospital of Chongqing Medical University from September 2019 to July 2024 were collected and retrospectively analyzed, including medical history, laboratory examination, pregnancy outcome, treatment options, and renal function outcome. To summarize the experience of prenatal counseling, pregnancy management, dialysis indications and lifestyle intervention in pregnant women with CKD stage 4-5. Results: A total of 10 pregnant women with CKD stage 4-5 were enrolled, aged (29.0±4.2) years (range: 23 to 36 years). Among the 10 cases, 3 cases were induced abortion in the second trimester, 1 case had missed abortion in the first trimester, and 6 cases were finally delivered successfully. Renal biopsy was performed in 4 cases to determine the type of primary nephropathy, and genetic testing was performed in 4 cases to confirm the diagnosis of hereditary nephropathy. Among the six CKD stage 4-5 pregnant women who successfully delivered, three started dialysis treatment in the second and third trimesters of pregnancy, and the other three started dialysis treatment immediately, 5.5 months and 18.3 months after delivery, respectively. All pregnant women were terminated by cesarean section and none of them had postpartum hemorrhage. The gestational age at delivery was (33.8±1.1) weeks (range: 32+1 to 35+1 weeks). All neonates were premature, with no fetal death and neonatal death. Two cases were small for gestational age and the other four were appropriate for gestational age. The length of neonatal intensive care unit (NICU) stay was (23.0±11.0) days (range: 10 to 38 days). No serious complications occurred during NICU stay. All newborns grew and developed well during the follow-up period of 10-60 months. Conclusions: CKD stage 4-5 is not an absolute contraindication for pregnancy. Comprehensive evaluation of doctor-patient shared decision-making on the premise of sufficient doctor-patient communication, precise management of MDT, close maternal and fetal monitoring, lifestyle medical intervention and timely initiation of dialysis can help pregnant women with CKD stage 4-5 achieve safe pregnancy and good maternal and fetal outcomes. 目的: 分析慢性肾脏病(CKD)4~5期孕妇的临床特点、治疗方案及母儿近远期结局。 方法: 收集2019年9月至2024年7月重庆医科大学附属第三医院CKD妊娠多学科团队(MDT)管理门诊接诊的CKD 4~5期孕妇的临床资料并进行回顾性分析(重点分析成功分娩孕妇),包括病史、实验室检查、妊娠结局、治疗方案、肾功能转归等,总结CKD 4~5期孕妇的产前咨询、妊娠期管理、透析指征、生活方式干预等治疗经验。 结果: 共纳入CKD 4~5期孕妇10例,年龄为(29.0±4.2)岁(范围:23~36岁)。10例孕妇中,3例于妊娠中期引产,1例于妊娠早期稽留流产,最终成功分娩6例;4例行肾穿刺活检明确原发性肾病类型,4例完善基因检测确诊为遗传性肾病。成功分娩的6例CKD 4~5期孕妇中,3例妊娠中晚期开始启动透析治疗,另3例分别于产后即刻、产后5.5月、产后18.3月开始启动透析治疗。所有孕妇均行剖宫产术终止妊娠,分娩孕周(33.8±1.1)周(范围:32+1~35+1周),均为早产儿,无胎死宫内及新生儿死亡,均无产后出血。2例为小于胎龄儿,其余4例为适于胎龄儿。新生儿重症监护病房(NICU)入住时间(23.0±11.0)d(范围:10~38 d),入住NICU期间均无严重并发症发生。随访新生儿10~60个月,均生长发育良好。 结论: CKD 4~5期非妊娠绝对禁忌,全面评估充分医患沟通前提下的医患共同决策、MDT精准管理、密切母胎监测、生活方式医学干预和适时启动透析,可以助力CKD 4~5期孕妇安全孕育并获得良好的母儿结局。.
引用
- Zuo XZ, Yang XL, Mao X, et al. [Clinical characteristics and maternal and fetal outcomes of pregnancy complicated with chronic kidney disease stage 4-5]. Zhonghua Fu Chan Ke Za Zhi. 2025. PMID: 41456894. doi:10.3760/cma.j.cn112141-20250712-00320
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。